The current authors done an open up-label pilot study that administered psilocybin to 15 therapy-resistant tobacco/nicotine-dependent smokers, while in the context of cognitive behavioral therapy for using tobacco cessation [fifty eight]. Members ended up administered ~0.29 mg/kg oral psilocybin aro